JPMorgan Upgrades Integra LifeSciences (IART) to Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Integra LifeSciences Reports Second Quarter 2015 Financial Results
July 30, 2015 6:00 AM EDTRevenue Increased 5.5% to $244.1 Million
Reported EPS of $0.15; Adjusted EPS Increased 16% to $0.79
Full Year 2015 Revenue and EPS Guidance Updated for SeaSpine Spin-off and TEI Acquisition
PLAINSBORO, N.J., July 30, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported its financial results for the second quarter ending June 30, 2015.
Highlights:
Second quarter... More